CREB1 and acute myeloid leukemia: In this study, we demonstrate that niclosamide inhibits CREB-driven gene expression by preventing CREB activation, thereby disrupting CREB-CBP interaction leading to induction of apoptosis and cell cycle arrest in AML cells.